Answers are grounded in this paper and cite their sources.
Plastic bronchitis (PB) is a severe complication of Mycoplasma pneumoniae pneumonia (MPP), causing bronchial casts and airway blockage. Managing PB with macrolide-resistant Mycoplasma pneumoniae (MRMP) is challenging, especially in patients unable to tolerate standard second-line antibiotics. We present the rare case of a child with MRMP-related PB resistant to azithromycin and intolerant to levofloxacin and doxycycline, ultimately treated with acetylmidecamycin. A 6-year-old boy had persistent fever and dry cough that failed to respond to two courses of azithromycin. On admission, levofloxacin was initiated but discontinued after 3 days due to myalgia and knee pain. Targeted next-generation sequencing (tNGS) confirmed the A2063G mutation in MRMP, and doxycycline was prescribed but discontinued after 1 day due to a generalized rash. In the absence of alternative treatments, acetylmidecamycin was administered as a salvage therapy. Bronchoscopy revealed branching casts occluding left lingular and lower lobes, confirming PB, and chest CT showed left lung consolidation with atelectasis and pleural effusion. The patient was discharged after 5 days of treatment, and at 1-month follow-up, respiratory symptoms had resolved, with significant absorption of lung consolidation and pleural effusion. This unprecedented case highlights the challenge of managing severe PB in areas with high MRMP prevalence when multiple antibiotics are contraindicated. Acetylmidecamycin, a 16-membered macrolide with a favorable safety profile in children, may be a potential alternative, pending further validation of its efficacy against MRMP. It highlights the necessity for individualized management and prompt bronchoscopic intervention in MRMP pneumonia with PB.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: